FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1197382008: Product containing precisely activated charcoal 813 milligram/1 gram granules for conventional release oral suspension (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
4696167018 Activated charcoal 813 mg/g granules for oral suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
4696168011 Product containing precisely activated charcoal 813 milligram/1 gram granules for conventional release oral suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Activated charcoal 813 mg/g granules for oral suspension Is a Product containing only activated charcoal (medicinal product) true Inferred relationship Some
Activated charcoal 813 mg/g granules for oral suspension Has manufactured dose form Granules for oral suspension true Inferred relationship Some
Activated charcoal 813 mg/g granules for oral suspension Has basis of strength substance (attribute) Activated charcoal true Inferred relationship Some 1
Activated charcoal 813 mg/g granules for oral suspension Has concentration strength denominator unit g true Inferred relationship Some 1
Activated charcoal 813 mg/g granules for oral suspension Has concentration strength numerator unit mg true Inferred relationship Some 1
Activated charcoal 813 mg/g granules for oral suspension Has precise active ingredient Activated charcoal true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start